Next Article in Journal
Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
Next Article in Special Issue
Investigating the Suitability of High Content Image Analysis as a Tool to Assess the Reversibility of Foamy Alveolar Macrophage Phenotypes In Vitro
Previous Article in Journal
Evaluation of the Solid Dispersion System Engineered from Mesoporous Silica and Polymers for the Poorly Water Soluble Drug Indomethacin: In Vitro and In Vivo
Previous Article in Special Issue
Pulmonary Metabolism of Substrates for Key Drug-Metabolizing Enzymes by Human Alveolar Type II Cells, Human and Rat Lung Microsomes, and the Isolated Perfused Rat Lung Model
 
 
Article

Article Versions Notes

Pharmaceutics 2020, 12(2), 145; https://doi.org/10.3390/pharmaceutics12020145
Action Date Notes Link
article xml file uploaded 11 February 2020 09:19 CET Original file -
article pdf uploaded. 11 February 2020 09:19 CET Version of Record https://www.mdpi.com/1999-4923/12/2/145/pdf-vor
article supplementary file uploaded. 11 February 2020 09:19 CET - https://www.mdpi.com/1999-4923/12/2/145#supplementary
article xml file uploaded 1 March 2020 03:24 CET Update -
article xml uploaded. 1 March 2020 03:24 CET Update https://www.mdpi.com/1999-4923/12/2/145/xml
article pdf uploaded. 1 March 2020 03:24 CET Updated version of record https://www.mdpi.com/1999-4923/12/2/145/pdf
article html file updated 1 March 2020 03:26 CET Original file -
article html file updated 6 March 2020 11:04 CET Update -
article html file updated 20 July 2022 19:49 CEST Update https://www.mdpi.com/1999-4923/12/2/145/html
Back to TopTop